Pyridostigmine Bromide Tablet
Product Images NDC 72458-128

5 FDA label images from Surgeon General-department Of The Army (tsg-da) · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pyridostigmine Bromide (NDC 72458-128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Surgeon General-department Of The Army (tsg-da), these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Pyridostigmine 01)

Chemical Structure (Pyridostigmine 01)
Chemical structure diagram of Pyridostigmine Bromide, showing its molecular arrangement including the pyridinium ring, ester linkage, and bromide ion.*
FDA Label Image

Principal Display Panel (21 Tablet Blister Pack)

Principal Display Panel (21 Tablet Blister Pack)
Pyridostigmine Bromide Tablets USP, 30 mg, oral tablets, with a quantity of 21 tablets. The label includes cautionary information about possible side effects and warnings, directions to stop taking if exposed to Soman nerve agent or gas attack alarm, and notes the product is for prescription use only. Manufactured by Bausch Health Companies Inc. for the US Department of Defense. The NDC is 72458-128-01.*
FDA Label Image

Principal Display Panel (2100 Tablet Blister Pack Bag Label)

Principal Display Panel (2100 Tablet Blister Pack Bag Label)
Pyridostigmine Bromide Tablets, USP, 30 mg oral tablets labeled for prescription use. Contains 2100 tablets in 10 blister packs. Manufactured by Bausch Health Companies Inc. for the US Department of Defense. Label includes storage instructions to refrigerate between 2°C to 8°C and guidance on storage after removal from refrigeration. The label displays multiple barcodes and batch-related placeholders.*
FDA Label Image

Principal Display Panel (21 Tablet Blister Pack Label)

Principal Display Panel (21 Tablet Blister Pack Label)
Packaging label for Pyridostigmine Bromide Tablets, USP, 30 mg, oral tablets. The label indicates each tablet contains 30 mg of Pyridostigmine Bromide and the package quantity is 1 blister pack of 21 tablets. It includes storage instructions to keep refrigerated between 2°C to 8°C (36°F to 46°F) and a discard guideline of 14 months after removal from the overwrap or after expiration date. Manufacturer is Bausch Health Companies Inc., Laval, Quebec for the US Department of Defense. The product bears NSN 6505-01-178-7903 and NDC 72458-128.*
FDA Label Image

Principal Display Panel (210 Tablet Blister Pack Package Label)

Principal Display Panel (210 Tablet Blister Pack Package Label)
Label for Pyridostigmine Bromide tablets, USP 30 mg, under NDC 72458-128-04, designated for prescription use only. The label identifies the product as a Soman Nerve Agent Pretreatment Pyridostigmine (SNAPP) and indicates a unit of issue as one package containing 10 blister packs with a total of 210 tablets. It includes storage instructions and manufacturer information, listing Bausch Health Companies Inc. as the manufacturer for the US Department of Defense.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.